Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2003
04/24/2003WO2002016615A3 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
04/24/2003WO2002014554A3 The anti-neoplastic agent et-743 inhibits trans activation by sxr
04/24/2003WO2002014527A3 Gp64-null baculoviruses pseudotyped with heterologous envelope proteins
04/24/2003WO2002014483A3 Human adenosine deaminase
04/24/2003WO2002012447A3 Isolation and use of solid tumor stem cells
04/24/2003WO2002008273A3 47508, a novel human histone deacetylase family member and uses thereof
04/24/2003WO2002007504A3 Hybrid soybeans and methods of production
04/24/2003WO2002006490A8 Lipoxygenase genes, promoters, transit peptides and proteins thereof
04/24/2003WO2002006342A3 G-protein coupled receptors and nucleic acids encoding same
04/24/2003WO2002004513A3 Down syndrome critical region 1-like 1 proteins
04/24/2003WO2002000940A3 Image analysis for phenotyping sets of mutant cells
04/24/2003WO2002000878A3 Human msp1 mitochondrial dynamin, its msp1-x isoforms, and their therapeutic use
04/24/2003WO2001083821A3 Polynucleotide probes for detection and quantitation of candida species
04/24/2003WO2001080900A3 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane
04/24/2003WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor
04/24/2003WO2001077389A3 Genes expressed in foam cell differentiation
04/24/2003WO2001075440A3 Schizophrenia related genes
04/24/2003US20030079255 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
04/24/2003US20030079254 Enhanced plant cell transformation by addition of host genes involved in T-DNA integration
04/24/2003US20030079253 Immunoglobulin binding protein arrays in eukaryotic cells
04/24/2003US20030079252 Transgenic plant for use as model in controlling flowering in plants
04/24/2003US20030079251 Nucleotide sequences coding polypeptide for use in enhancing digestibility of plants, improving gum extractability from plants, and altering plant propagation
04/24/2003US20030079250 Nucleotide sequences coding polypetide for use in the modification of fatty acids in plants
04/24/2003US20030079249 Nucleotide sequences coding polypeptide for use in altering the composition of plant oils, waxes and hydroxylated fatty acids in plants
04/24/2003US20030079248 Nucleotide sequences coding polypeptide for use in generation of vaccines in plants
04/24/2003US20030079247 Nucleotide sequences codin polypeptide for use in the preparation of corn or soy animal feeds
04/24/2003US20030079246 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants
04/24/2003US20030079243 Transgenic mice containing TRP6 calcium ion channel gene disruptions
04/24/2003US20030079241 Isolation of precancerous tissue; obtain mammary gland tissue from cancer prone rodent, implant cells into nontrangenic rodent, detect propagation of cells, generate clonal series from propagating cells
04/24/2003US20030079240 Chimeric embryos and animals containing human cells
04/24/2003US20030079238 Polynucleotide encoding a human junctional adhesion protein (JAM-2)
04/24/2003US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
04/24/2003US20030079235 Assay for measuring enzyme activity in vivo
04/24/2003US20030078412 Reagent for the isolation of RNA
04/24/2003US20030078411 Adeno-associated virus capsid immunologic determinants
04/24/2003US20030078410 Expression vector for use in the transfer of genes and preparation of vaccines
04/24/2003US20030078409 Nucleotide sequences coding polypeptide for use in the treatment of respiratory system, asthmatic and inflammatory bowel diseases
04/24/2003US20030078406 Methods and compositions for DRM, a secreted protein with cell growth inhibiting activity
04/24/2003US20030078405 47 human secreted proteins
04/24/2003US20030078402 Expression library for use in the generation of preferential immunoglobulins
04/24/2003US20030078398 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
04/24/2003US20030078395 Nucleotide sequences coding polypeptide for use in the treatment of hyperlipemia
04/24/2003US20030078391 Nucleotide sequences coding polypeptide for use in treatment of periodontal disease
04/24/2003US20030078390 Tissue cement proteins from Rhipicephalus appendiculatus
04/24/2003US20030078389 Gamma-heregulin
04/24/2003US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders
04/24/2003US20030078383 Novel human LDL receptor family proteins and polynucleotides encoding the same
04/24/2003US20030078382 Human Ect2 and methods of use
04/24/2003US20030078377 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
04/24/2003US20030078373 Chaperone fragments
04/24/2003US20030078370 Antibodies to cyclin E2 protein
04/24/2003US20030078314 Methods and compositions for attachment of biomolecules to solid supports, hydrogels, and hydrogel arrays
04/24/2003US20030078230 Stabilizing, shaping to form particles and determining a turbidity parameter of a solution of compacted nucleic acid; drug delivery of DNA to cells, transfection
04/24/2003US20030078229 Lyophilizable and enhanced compacted nucleic acids
04/24/2003US20030078225 Liposomes
04/24/2003US20030078224 An isolated polynucleotide for treating prostate and non-prostate tumors in a gene therapy
04/24/2003US20030078222 Human receptor tyrosine kinase
04/24/2003US20030078221 Method for treating a Complement System-mediated disease comprising administering a pharmaceutically effective amount of a Nucleic Acid Ligand of a Complement System Protein; SELEX method
04/24/2003US20030078220 Invention provides genetic variants of the human Interleukin 4 Receptor Alpha (IL4R alpha ) gene and methods for identifying which variants of this gene are possessed by an individual
04/24/2003US20030078219 Compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 2; cancer therapy
04/24/2003US20030078217 Antisense modulation of transforming growth factor-beta 3 expression
04/24/2003US20030078216 By means of antisense oligonucleotide that inhibits expression of histone deacetylase.
04/24/2003US20030078192 Chimeric open reading frames; genetic engineering
04/24/2003US20030078177 Proteases from gram positive organisms
04/24/2003US20030077839 Method and apparatus for recovering biomolecules
04/24/2003US20030077831 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering
04/24/2003US20030077830 Ketogulonigenium endogenous plasmids
04/24/2003US20030077829 Lipid-based formulations
04/24/2003US20030077828 Methods for highly efficient generation of adenoviral vectors
04/24/2003US20030077827 Transfection of preferential cells; obtain immbolized nucleotide sequences, incubate with cells, recover transfected cells
04/24/2003US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
04/24/2003US20030077824 Production of cultured human mast cells and basophils for high throughput small molecule drug discovery
04/24/2003US20030077823 Hair follicle stem cells for use in the treatment of nervous system disorders and cell therapy
04/24/2003US20030077820 Novel human collagen proteins and polynucleotides encoding the same
04/24/2003US20030077812 Lentiviral vectors encoding clotting factors for gene therapy
04/24/2003US20030077810 CHAMP - a novel cardiac helicase-like factor
04/24/2003US20030077809 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and skin disorders
04/24/2003US20030077807 Subtilisin variants
04/24/2003US20030077806 Composition for use in the treatment of lysosomal storage defects
04/24/2003US20030077805 Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof
04/24/2003US20030077804 Composition containing protein for use as cloning tool in genetic engineering
04/24/2003US20030077802 Human PRL1 phosphatase
04/24/2003US20030077801 Herbicide resistant plants
04/24/2003US20030077798 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's, diabetes and inflammation
04/24/2003US20030077797 Xylitol dehydrogenase of acetic acid bacteria and gene thereof
04/24/2003US20030077793 Catalytic antibody for use in the treatment of drug abuse and dependence
04/24/2003US20030077792 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077791 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077790 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077789 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077788 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077787 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077786 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077785 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077784 Secreted and transmembrane polypeptides and nucleic acids encoding the same
04/24/2003US20030077783 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077782 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077781 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder
04/24/2003US20030077780 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder